Management strategies for colorectal liver metastases--Part I.

scientific article published on January 1997

Management strategies for colorectal liver metastases--Part I. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0960-7404(97)00002-9
P698PubMed publication ID9364658

P2093author name stringPoston GJ
Kinsella AR
Hugh TJ
P2860cites workEarly detection of occult colorectal hepatic metastases using duplex colour Doppler sonographyQ72612427
Liver metastases from colorectal carcinoma: detection with Doppler US-guided measurements of liver blood flow--past, present, futureQ72635649
Intra-operative ultrasound for the detection of hepatic metastases from colorectal cancerQ72797693
Comparison of the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver metastases. Evaluation with postoperative follow-up resultsQ72854635
Superior staging of liver tumors with laparoscopy and laparoscopic ultrasoundQ24535519
Poorly differentiated colon carcinoma cell lines deficient in alpha-catenin expression express high levels of surface E-cadherin but lack Ca(2+)-dependent cell-cell adhesionQ28247836
Use of restriction fragment length polymorphisms to determine the clonal origin of human tumorsQ28286355
Increasing incidence of cecal and sigmoid carcinoma. Data from the Connecticut Tumor RegistryQ34210204
Outcome in colorectal adenocarcinoma: two seven-year studies of a populationQ35189388
The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasisQ35976891
Attitudes towards detection and management of hepatic metastases of colorectal origin: a second lookQ36712520
Surgical decision making for large bowel cancer metastatic to the liverQ38143479
Importance of hepatic artery node involvement in patients with colorectal liver metastasesQ39644615
Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancerQ39857794
Tumor Vascularity as a Prognostic Factor for Hepatic TumorsQ40037324
Liver MetastasesQ40307491
Biology of human colon cancer metastasisQ40527929
Port site metastases after laparoscopic colorectal surgery for cure of malignancyQ40553167
Molecular and cellular basis of cancer invasion and metastasis: implications for treatmentQ40574779
Patterns of colorectal liver metastases according to Couinaud's segmentsQ40608120
Tumor metastasis formation: cell-surface proteins confer metastasis-promoting or -suppressing properties.Q40760006
Growth rate and percentage hepatic replacement of colorectal liver metastasesQ40860904
Significance of tumor-host interactions in cancer growth and metastasesQ41121022
Imaging of primary and metastatic liver tumors.Q41340152
Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell linesQ41456506
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsiesQ41479079
Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cellsQ41601139
Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosisQ42179285
Measurement of response to treatment in colorectal liver metastasesQ42209034
The use of duplex sonography in the detection of colorectal hepatic metastasesQ42383584
Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cellsQ43651232
One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinantsQ43681655
Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural historyQ43990247
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastasesQ44102151
Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal veinQ44266901
Detection of colorectal liver metastases using intraoperative ultrasonographyQ44678820
Intraoperative ultrasound of the liver affects operative decision makingQ45021240
Cancer patient survival rates: SEER program results for 10 years of follow-upQ45816622
Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results.Q50599066
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.Q52693985
Ultrasonography of small hepatic tumors using high-resolution linear-array real-time instrumentsQ57205855
A proposed classification system for liver metastasis from colorectal carcinomaQ57225218
Intraoperative ultrasonography in detection of hepatic metastases from colorectal cancerQ57778716
Intraoperative Ultrasound Imaging of the Liver at the Time of Colorectal Cancer ResectionQ58005116
Cancer metastasis is selective or random depending on the parent tumour populationQ59068992
Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: evaluation with postoperative follow-up resultsQ67973056
Laparoscopic contact hepatic ultrasonographyQ68056486
Detection of hepatic metastases using duplex/color Doppler sonographyQ68060944
Detection by CT during arterial portography of colorectal cancer metastases to liverQ68189807
Liver tumor imaging: current conceptsQ68349945
Liver and abdominal screening in patients with cancer: CT versus MR imagingQ68400306
Growth rate of hepatic metastases in colorectal carcinomaQ68502130
Anechoic halo in solid liver tumors: sonographic, microangiographic, and histologic correlationQ68935635
Vascularization of small liver metastasesQ69089620
Resection of liver metastases--when is it worthwhile?Q69254608
Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imagingQ69336185
Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluationQ69513849
Occult hepatic metastases in colorectal carcinomaQ69614178
Relationship between colorectal liver metastases and CEA levels in gallbladder bileQ69771504
Liver metastases from colorectal cancers: detection with CT during arterial portographyQ69805894
Surgical treatment of hepatic metastases from colorectal cancerQ69993402
Deranged liver blood flow patterns in the detection of liver metastasesQ70057727
A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584Q70179809
Comparisons of dynamic infusion and delayed computed tomography, intraoperative ultrasound, and palpation in the diagnosis of liver metastasesQ70525999
False-positive CT portography: correlation with pathologic findingsQ70539064
Surgical treatment of hepatic metastases: impact of intraoperative sonographyQ70554681
Preoperative evaluation of patients for liver resection. Appropriate CT imagingQ70607377
Natural history of patients with untreated liver metastases from colorectal cancerQ70750008
Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survivalQ70992027
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resectionQ71289337
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie DigestiveQ71563224
Computed tomographic portography in preoperative imaging of hepatic neoplasmsQ71884963
Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous USQ71901818
Hepatic resection for metastases from colorectal carcinoma — A survival analysisQ72108955
Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowelQ72254111
Potential value of biliary CEA assay in early detection of colorectal adenocarcinoma liver metastasesQ72314520
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancerQ72420524
Impact of intraoperative ultrasonography on treatment strategy for colorectal cancerQ72424723
Prediction of surgical resectability in patients with hepatic colorectal metastasesQ72425031
P433issue1
P304page(s)19-30
P577publication date1997-01-01
P1433published inSurgical OncologyQ14421678
P1476titleManagement strategies for colorectal liver metastases--Part I.
P478volume6

Reverse relations

cites work (P2860)
Q33937325Ablative therapies for colorectal liver metastases: a systematic review
Q53066693Accuracy of water-enema multidetector computed tomography (WE-MDCT) in colon cancer staging: a prospective study.
Q38116093Close collaboration between local and specialist multidisciplinary teams allows 'fast-tracking' of patients with colorectal liver metastases
Q33205950Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer
Q33928158Contrast-enhanced intraoperative ultrasound improves detection of liver metastases during surgery for primary colorectal cancer
Q35918148Dual Energy Spectral CT Imaging for Colorectal Cancer Grading: A Preliminary Study
Q89849938Expanding the Scope of Immunotherapy in Colorectal Cancer: Current Clinical Approaches and Future Directions
Q84590272Liver abscess after liver metastasectomy is a poor prognostic factor in patients with colorectal cancer
Q26774687Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection
Q79196755Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic Metastases
Q73919223Radiofrequency thermal ablation of hepatic metastases
Q36220852Repeated Liver Resection for Colorectal Liver Metastases: A Comparison with Primary Liver Resections concerning Perioperative and Long-Term Outcome.
Q38186578Surgical margin size in hepatic resections for colorectal metastasis: impact on recurrence and survival
Q24651894Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies
Q43175212The case for neo-adjuvant chemotherapy. For.
Q38308022Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.

Search more.